Literature DB >> 7437286

Immunoglobulins associated with human tumours in vivo: IgG concentrations in eluates of colonic carcinomas.

J M MacSween, S L Eastwood.   

Abstract

The concentrations of IgG in acidic and 3MKCl eluates of resected colonic carcinomas and adjacent normal tissue were determined by radioimmunoassay. The mean concentration of IgG was significantly higher in both acidic and KCl eluates of primary Dukes Stage C tumours than Dukes Stage A tumours. These results provide direct evidence for increased fixation of IgG in vivo by human colonic cancers which had metastasized. Our results also raise the possibility that IgG is more tightly bound to the Stage C tumours. It is likely that this tumour-associated Ig represents antibody to tumour antigens or antigen-antibody complexes, bound to Fc receptors in the tumour.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437286      PMCID: PMC2010443          DOI: 10.1038/bjc.1980.272

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Correlation between clinico-pathological features of malignant tumors and cell surface immunoglobulins.

Authors:  F C Izsak; H J Brenner; E Landes; M Ran; I P Witz
Journal:  Isr J Med Sci       Date:  1974-06

2.  Tumor-specific antigen solubilized by hypertonic potassium chloride.

Authors:  M S Meltzer; E J Leonard; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

Review 3.  Specific antigens of tumors and leukemias of experimental animals.

Authors:  L J Old; E A Boyse
Journal:  Med Clin North Am       Date:  1966-05       Impact factor: 5.456

4.  Degradation of immunoglobulins by lysosomal enzymes of tumors. I. Demonstration of the phenomenon using mouse tumors.

Authors:  Y Keisari; I P Witz
Journal:  Immunochemistry       Date:  1973-09

5.  Enhancement of the C57BL leukemia E.L.4 by Fab fragments of isoantibody.

Authors:  T Chard; M E French; J R Batchelor
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

6.  Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

Authors:  H O Sjögren; I Hellström; S C Bansal; G A Warner; K E Hellström
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

7.  Stimulation of cells by antibody.

Authors:  W T Shearer; G W Philpott; C W Parker
Journal:  Science       Date:  1973-12-28       Impact factor: 47.728

8.  The immune reaction as a stimulator of tumor growth.

Authors:  R T Prehn
Journal:  Science       Date:  1972-04-14       Impact factor: 47.728

9.  Spontaneous shedding of TSTA by viable sarcoma cells: its possible role in facilitating metastatic spread.

Authors:  G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1974-01       Impact factor: 7.640

10.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  4 in total

1.  Effects of Chlorella vulgaris on tumor growth in mammary tumor-bearing Balb/c mice: discussing association of an immune-suppressed protumor microenvironment with serum IFNγ and IgG decrease and spleen IgG potentiation.

Authors:  Ahad Khalilnezhad; Elham Mahmoudian; Nariman Mosaffa; Ali Anissian; Mohsen Rashidi; Davar Amani
Journal:  Eur J Nutr       Date:  2017-02-22       Impact factor: 5.614

2.  Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Authors:  Kristi Baker; Timo Rath; Magdalena B Flak; Janelle C Arthur; Zhangguo Chen; Jonathan N Glickman; Inti Zlobec; Eva Karamitopoulou; Matthew D Stachler; Robert D Odze; Wayne I Lencer; Christian Jobin; Richard S Blumberg
Journal:  Immunity       Date:  2013-11-27       Impact factor: 31.745

3.  Elution of cytomegalovirus antibodies from adenocarcinoma of the colon.

Authors:  A Grail; M Norval
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

4.  Cells bearing Fc receptors in human malignant solid tumours.

Authors:  J L Svennevig; T R Andersson
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.